A new study from the University of Minnesota is the first to demonstrate the ability for gene therapy to repair neural connections for those with the rare genetic brain disorder known as Hurler syndrome.
AbbVie pours $223M into building out its biologics capacity in Singapore
AbbVie is not only building out its pipeline, but also its manufacturing footprint. The Chicago-based pharma is spending $223 million to extend its only manufacturing
January 27, 2024